Carlos Alfaras

Carlos Alfaras is a seasoned executive with extensive experience in the healthcare and pharmaceutical sectors. Currently serving as the Chief Executive Officer at Renoviant, Inc. since March 2022, Carlos emphasizes service excellence and customer success. As President & CEO of AHP Group since May 2008, Carlos has focused on comprehensive solutions for the pharmaceutical and institutional healthcare markets, including niche product sales, packaging, and supply chain management. Additional roles include Board Adviser at DimeTyd, Managing Partner & President at Evolution Ventures Group, and previous Chairman & CEO at Neo7Bioscience, Inc. Carlos's earlier experience includes being a strategic advisor at Verséa Holdings, CEO at Gensco Pharma, and an executive director at Actavis plc. Carlos holds a PreMed degree in Biochemistry from the University of Miami.